Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 65

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Altered conformational landscape and dimerization dependency underpins the activation of EGFR by α C– β 4 loop insertion mutations

Ruan, Zheng, Kannan, Natarajan · 2018 · Proceedings of the National Academy of Sciences

Abstract

Significance: The α C– β 4 loop is a conserved structural motif present in all eukaryotic protein kinases. This study focuses on epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that harbors many recurrent insertion mutations in the α C– β 4 loop. We show that EGFR activity and drug sensitivity are strongly dependent on the nature, size, and location of mutations in the loop and that even subtle variations in the loop have a dramatic effect on kinase dynamics and free-energy landscape. These findings inform ongoing drug-discovery efforts on EGFR kinases and provide a structural framework for investigating the role of the understudied α C– β 4 loop in kinase regulation, dynamics, and evolution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1803152115

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 53

  1. V Frattini, , The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet 45, 1141–1149 (2013). · DOI · Paper page
  2. KC Day, , Her2 and EGFR overexpression support metastatic progression of prostate cancer to bone. Cancer Res 77, 74–85 (2017). · DOI · Paper page
  3. H Masuda, , Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat 136, 331–345 (2012). · DOI · Paper page
  4. ME Arcila, , EGFR exon 20 insertion mutations in lung adenocarcinomas: Prevalence, molecular heterogeneity, and clinicopathologic characteristics. Mol Cancer Ther 12, 220–229 (2013). · DOI · Paper page
  5. DM Jackman, , Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin Cancer Res 12, 3908–3914 (2006). · DOI · Paper page
  6. CJ Tsai, R Nussinov, The molecular basis of targeting protein kinases in cancer therapeutics. Semin Cancer Biol 23, 235–242 (2013). · DOI
  7. Y Shan, , Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. Cell 149, 860–870 (2012). · DOI · Paper page
  8. SA Foster, , Activation mechanism of oncogenic deletion mutations in BRAF, EGFR, and HER2. Cancer Cell 29, 477–493 (2016). · DOI · Paper page
  9. H Yasuda, S Kobayashi, DB Costa, EGFR exon 20 insertion mutations in non-small-cell lung cancer: Preclinical data and clinical implications. Lancet Oncol 13, e23–e31 (2012). · DOI · Paper page
  10. JP Dawson, , Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell. Biol 25, 7734–7742 (2005). · DOI · Paper page
  11. Y Huang, , Molecular basis for multimerization in the activation of the epidermal growth factor receptor. Elife 5, e14107 (2016). · DOI · Paper page
  12. Z Wang, , Mechanistic insights into the activation of oncogenic forms of EGF receptor. Nat Struct Mol Biol 18, 1388–1393 (2011). · DOI
  13. J Cho, , Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab. Mol Cancer 13, 141 (2014). · DOI
  14. Z Ruan, N Kannan, Mechanistic insights into R776H mediated activation of epidermal growth factor receptor kinase. Biochemistry 54, 4216–4225 (2015). · DOI
  15. Z Ruan, S Katiyar, N Kannan, Computational and experimental characterization of patient derived mutations reveal an unusual mode of regulatory spine assembly and drug sensitivity in EGFR kinase. Biochemistry 56, 22–32 (2017). · DOI
  16. S Li, , Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7, 301–311 (2005). · DOI · Paper page
  17. MD Fulton, , Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation. Bioorg Med Chem 26, 1167–1173 (2017). · DOI
  18. Y Shan, A Arkhipov, ET Kim, AC Pan, DE Shaw, Transitions to catalytically inactive conformations in EGFR kinase. Proc Natl Acad Sci USA 110, 7270–7275 (2013). · DOI · Paper page
  19. KA White, , Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins. Sci Signal 10, eaam9931 (2017). · DOI
  20. DD Wang, W Zhou, H Yan, M Wong, V Lee, Personalized prediction of EGFR mutation-induced drug resistance in lung cancer. Sci Rep 3, 2855 (2013). · DOI
  21. L Ma, , EGFR mutant structural database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib. BMC Bioinformatics 16, 85 (2015). · DOI
  22. S Kannan, , Hydration effects on the efficacy of the epidermal growth factor receptor kinase inhibitor afatinib. Sci Rep 7, 1540 (2017). · DOI
  23. Y Li, X Li, W Ma, Z Dong, Conformational transition pathways of epidermal growth factor receptor kinase domain from multiple molecular dynamics simulations and Bayesian clustering. J Chem Theor Comput 10, 3503–3511 (2014). · DOI
  24. AC Pan, TM Weinreich, Y Shan, DP Scarpazza, DE Shaw, Assessing the accuracy of two enhanced sampling methods using EGFR kinase transition pathways: The influence of collective variable choice. J Chem Theor Comput 10, 2860–2865 (2014). · DOI
  25. L Sutto, FL Gervasio, Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase. Proc Natl Acad Sci USA 110, 10616–10621 (2013). · DOI · Paper page
  26. H Chen, , A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol Cell. 27, 717–730 (2007). · DOI · Paper page
  27. T Klein, , Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinase. Nat Commu 6, 7877 (2015). · DOI
  28. N Kannan, AF Neuwald, Did protein kinase regulatory mechanisms evolve through elaboration of a simple structural component? J Mol Biol 351, 956–972 (2005). · DOI · Paper page
  29. W Xu, , Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex. Nat Struct Mol Biol 12, 120–126 (2005). · DOI
  30. JT den Dunnen, SE Antonarakis, Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15, 7–12 (2000). · DOI · Paper page
  31. DI McSkimming, , Prokino: A unified resource for mining the cancer kinome. Hum Mutat 36, 175–186 (2015). · DOI
  32. K Politi, TJ Lynch, Two sides of the same coin: EGFR exon 19 deletions and insertions in lung cancer. Clin Cancer Res 18, 1490–1492 (2012). · DOI
  33. M Red Brewer, , Mechanism for activation of mutated epidermal growth factor receptors in lung cancer. Proc Natl Acad Sci USA 110, E3595–E3604 (2013). · DOI
  34. N Minkovsky, A Berezov, BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors. Curr Opin Investig Drugs 9, 1336–1346 (2008).
  35. Y Yosaatmadja, , Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed. J Struct Biol 192, 539–544 (2015). · DOI
  36. DI McSkimming, K Rasheed, N Kannan, Classifying kinase conformations using a machine learning approach. BMC Bioinformatics 18, 86 (2017). · DOI
  37. Y Kawakita, , Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors. Bioorg Med Chem 21, 2250–2261 (2013). · DOI
  38. E Sajnaga, K Kubiński, R Szyszka, Catalytic activity of mutants of yeast protein kinase CK2alpha. Acta Biochim Pol 55, 767–776 (2008). · doi:10.18388/abp.2008_3039
  39. ED Scheeff, J Eswaran, G Bunkoczi, S Knapp, G Manning, Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure 17, 128–138 (2009). · DOI · Paper page
  40. JCK Ngo, , SR protein kinase 1 is resilient to inactivation. Structure 15, 123–133 (2007). · DOI
  41. S Meinhardt, MWJ Manley, DJ Parente, L Swint-Kruse, Rheostats and toggle switches for modulating protein function. PLoS One 8, e83502 (2013). · DOI
  42. W Xu, , Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition. Br J Cancer 97, 741–744 (2007). · DOI
  43. N Eswar, , Comparative protein structure modeling using modeller. Curr Protoc Bioinformatics Chapter 5, Unit-U5.6 (2006).
  44. DJ Mandell, EA Coutsias, T Kortemme, Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling. Nat Methods 6, 551–552 (2009). · DOI · Paper page
  45. MJ Abraham, , Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015). · DOI · Paper page
  46. M Bonomi, , Plumed: A portable plugin for free-energy calculations with molecular dynamics. Comput Phys Commun 180, 1961–1972 (2009). · DOI · Paper page
  47. K Lindorff-Larsen, , Improved side-chain torsion potentials for the Amber ff99sB protein force field. Proteins 78, 1950–1958 (2010). · DOI · Paper page
  48. S Páll, B Hess, A flexible algorithm for calculating pair interactions on SIMD architectures. Comput Phys Commun 184, 2641–2650 (2013). · DOI · Paper page
  49. G Bussi, D Donadio, M Parrinello, Canonical sampling through velocity rescaling. J Chem Phys 126, 014101 (2007). · DOI · Paper page
  50. HJC Berendsen, JPM Postma, G WFv, A DiNola, JR Haak, Molecular dynamics with coupling to an external bath. J Chem Phys 81, 3684–3690 (1984). · DOI · Paper page
  51. S Kumar, D Bouzida, RH Swendsen, PA Kollman, JM Rosenberg, The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. J Comput Chem 13, 1011–1021 (1992). · DOI · Paper page
  52. MK Scherer, , PyEMMA 2: A software package for estimation, validation, and analysis of Markov models. J Chem Theor Comput 11, 5525–5542 (2015). · DOI · Paper page
  53. B Ensing, A Laio, M Parrinello, ML Klein, A recipe for the computation of the free energy barrier and the lowest free energy path of concerted reactions. J Phys Chem B 109, 6676–6687 (2005). · DOI · Paper page

Cited by

See all 65

Metadata

Authors
Ruan, Z., & Kannan, N.
Affiliations
Institute of Bioinformatics, University of Georgia, Athens, GA 30602;
Venue
Proceedings of the National Academy of Sciences
Published
2018-08-13
Volume
115
Issue
35
ISSN
  • 0027-8424
  • 1091-6490
Cited by
65
References
14
Language
en
Funders
HHS | National Institutes of Health (5RO1GM114409)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Altered conformational landscape and dimerization dependency underpins the activation of EGFR by α C– β 4 loop insertion mutations. https://app.cochat.ai/papers/10.1073/pnas.1803152115
The paper
Ruan, Z., & Kannan, N. (2018). Altered conformational landscape and dimerization dependency underpins the activation of EGFR by α C– β 4 loop insertion mutations. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1803152115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.